Compare Aehr Test Systems (AEHR) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aehr Test Systems vs Amylx Pharmaceuticals Inc — how do they compare? Aehr Test Systems trades at $124.86 (market cap $3.82B), while Amylx Pharmaceuticals Inc trades at $23.66 (market cap $2.64B). The key difference: Aehr Test Systems is the larger of the two by market cap, and Aehr Test Systems is trading nearer its 52-week high, Amylx Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AEHR | AMLX | |
|---|---|---|
Market Cap | $3.82B | $2.64B |
Sector | Technology | Health |
52-Week High | $117.18 | $24.19 |
52-Week Low | $17.38 | $7.82 |
Enterprise Value | $3.72B | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
